These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 2811561)
1. Rhabdomyosarcoma of the ear and temporal bone. Wiatrak BJ; Pensak ML Laryngoscope; 1989 Nov; 99(11):1188-92. PubMed ID: 2811561 [TBL] [Abstract][Full Text] [Related]
2. [The outcome of treatments for carcinoma of the external auditory canal]. Schmerber S; Righini Ch; Soriano E; Delalande C; Dumas G; Reyt E; Lavieille JP Rev Laryngol Otol Rhinol (Bord); 2005; 126(3):165-70. PubMed ID: 16366384 [TBL] [Abstract][Full Text] [Related]
3. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. Meza JL; Anderson J; Pappo AS; Meyer WH; J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036 [TBL] [Abstract][Full Text] [Related]
4. Rhabdomyosarcoma of the ear-mastoid. Deutsch M; Felder H Laryngoscope; 1974 Apr; 84(4):586-92. PubMed ID: 4821517 [No Abstract] [Full Text] [Related]
5. Embryonal rhabdomyosarcoma of the temporal bone. Viswanatha B Ear Nose Throat J; 2007 Apr; 86(4):218, 220-2. PubMed ID: 17500393 [TBL] [Abstract][Full Text] [Related]
6. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma. Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519 [TBL] [Abstract][Full Text] [Related]
7. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080 [TBL] [Abstract][Full Text] [Related]
8. Genital rhabdomyosarcoma: current management and review of the literature. Bell J; Averette H; Davis J; Toledano S Obstet Gynecol Surv; 1986 May; 41(5):257-63. PubMed ID: 3517719 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997. Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM; J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347 [TBL] [Abstract][Full Text] [Related]
10. [Pediatric rhabdomyosarcoma of the infratemporal fossa]. Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115 [TBL] [Abstract][Full Text] [Related]
11. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550 [TBL] [Abstract][Full Text] [Related]
12. Sarcoma of the prostate: a single institutional review. Janet NL; May AW; Akins RS Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120 [TBL] [Abstract][Full Text] [Related]
13. Rhabdomyosarcoma of the middle ear and mastoid in children. Said H; Phang KS; Razi A; Khuzaiyah R; Patawari PH; Esa R J Laryngol Otol; 1988 Jul; 102(7):614-9. PubMed ID: 3411216 [TBL] [Abstract][Full Text] [Related]
14. Embryonal rhabdomyosarcoma of the head and neck in children. Sessions DG; Ragab AH; Vietti TJ; Biller HF; Ogura JH Laryngoscope; 1973 Jun; 83(6):890-7. PubMed ID: 4351166 [No Abstract] [Full Text] [Related]
15. Combined therapy for middle ear rhabdomyosarcoma. Cunningham D; Kung FH Am J Dis Child; 1972 Sep; 124(3):401-2. PubMed ID: 5056879 [No Abstract] [Full Text] [Related]
16. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group. Spunt SL; Smith LM; Ruymann FB; Qualman SJ; Donaldson SS; Rodeberg DA; Anderson JR; Crist WM; Link MP Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6072-9. PubMed ID: 15447992 [TBL] [Abstract][Full Text] [Related]
17. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858 [TBL] [Abstract][Full Text] [Related]
18. [Rhabdomyosarcoma]. Hosoi H; Tsuchiya K; Sugimoto T Gan To Kagaku Ryoho; 2007 Feb; 34(2):181-6. PubMed ID: 17301524 [TBL] [Abstract][Full Text] [Related]
19. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group. Arndt CA; Hawkins DS; Meyer WH; Sencer SF; Neglia JP; Anderson JR Pediatr Blood Cancer; 2008 Jan; 50(1):33-6. PubMed ID: 17091486 [TBL] [Abstract][Full Text] [Related]
20. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary? Schuck A; Mattke AC; Schmidt B; Kunz DS; Harms D; Knietig R; Treuner J; Koscielniak E J Clin Oncol; 2004 Jan; 22(1):143-9. PubMed ID: 14701776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]